Brief: Titan Pharmaceuticals Receives Funding To Develop Combination HIV Therapeutic And Contraceptive Implant
25/10/2021 12:20
Oct 25 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS RECEIVES FUNDING TO DEVELOP
COMBINATION
HIV THERAPEUTIC AND CONTRACEPTIVE IMPLANT FOR WOMEN IN
DEVELOPING COUNTRIES
Source text for Eikon: ID:nPn6qWpBpa
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.